183 related articles for article (PubMed ID: 18032029)
21. Suppression of graft-versus-host disease after adoptive infusion of alloreactive NK cells induced by silencing Ly49C gene in mice.
Cao D; Hu L; Wang Y; Wang L; Zheng W; Ma W
Transpl Immunol; 2009 Mar; 20(4):243-8. PubMed ID: 19010415
[TBL] [Abstract][Full Text] [Related]
22. Markers and function of human NK cells in normal and pathological conditions.
Del Zotto G; Marcenaro E; Vacca P; Sivori S; Pende D; Della Chiesa M; Moretta F; Ingegnere T; Mingari MC; Moretta A; Moretta L
Cytometry B Clin Cytom; 2017 Mar; 92(2):100-114. PubMed ID: 28054442
[TBL] [Abstract][Full Text] [Related]
23. [Effect of small interfering RNA-mediated silencing of CD158b expression on the cytotoxicity of NK cells against the allogeneic dendritic cells].
Cao DL; Chen W; Ma WL
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(9):1603-5, 1613. PubMed ID: 18819877
[TBL] [Abstract][Full Text] [Related]
24. Human natural killer cells in health and disease.
Shereck E; Satwani P; Morris E; Cairo MS
Pediatr Blood Cancer; 2007 Oct; 49(5):615-23. PubMed ID: 17265453
[TBL] [Abstract][Full Text] [Related]
25. Effects of the NK cell recovery on outcomes of unmanipulated haploidentical blood and marrow transplantation for patients with hematologic malignancies.
Chang YJ; Zhao XY; Huang XJ
Biol Blood Marrow Transplant; 2008 Mar; 14(3):323-34. PubMed ID: 18275899
[TBL] [Abstract][Full Text] [Related]
26. Graft-versus-disease effect following allogeneic transplantation for acute leukaemia.
Rowe JM
Best Pract Res Clin Haematol; 2008 Sep; 21(3):485-502. PubMed ID: 18790451
[TBL] [Abstract][Full Text] [Related]
27. HLA-E upregulation on IFN-gamma-activated AML blasts impairs CD94/NKG2A-dependent NK cytolysis after haplo-mismatched hematopoietic SCT.
Nguyen S; Beziat V; Dhedin N; Kuentz M; Vernant JP; Debre P; Vieillard V
Bone Marrow Transplant; 2009 May; 43(9):693-9. PubMed ID: 19011664
[TBL] [Abstract][Full Text] [Related]
28. Association of bone marrow natural killer cell dose with neutrophil recovery and chronic graft-versus-host disease after HLA identical sibling bone marrow transplants.
Larghero J; Rocha V; Porcher R; Filion A; Ternaux B; Lacassagne MN; Robin M; Peffault de Latour R; Devergie A; Biscay N; Ribaud P; Benbunan M; Gluckman E; Marolleau JP; Socié G
Br J Haematol; 2007 Jul; 138(1):101-9. PubMed ID: 17555453
[TBL] [Abstract][Full Text] [Related]
29. Natural killer receptors and graft-vs.-host/ graft-vs.-leukaemia reactions.
Jones DC; Young NT
Vox Sang; 2004 Jul; 87 Suppl 2():15-7. PubMed ID: 15209869
[No Abstract] [Full Text] [Related]
30. Natural killer cells in human health and disease.
Orange JS; Ballas ZK
Clin Immunol; 2006 Jan; 118(1):1-10. PubMed ID: 16337194
[TBL] [Abstract][Full Text] [Related]
31. Human NK cells and their receptors.
Moretta L; Biassoni R; Bottino C; Cantoni C; Pende D; Mingari MC; Moretta A
Microbes Infect; 2002 Dec; 4(15):1539-44. PubMed ID: 12505526
[TBL] [Abstract][Full Text] [Related]
32. Donor KIR3DL1/3DS1 gene and recipient Bw4 KIR ligand as prognostic markers for outcome in unrelated hematopoietic stem cell transplantation.
Gagne K; Busson M; Bignon JD; Balère-Appert ML; Loiseau P; Dormoy A; Dubois V; Perrier P; Jollet I; Bois M; Masson D; Moine A; Absi L; Blaise D; Charron D; Raffoux C;
Biol Blood Marrow Transplant; 2009 Nov; 15(11):1366-75. PubMed ID: 19822295
[TBL] [Abstract][Full Text] [Related]
33. Selective depletion of alloreactive T lymphocytes using patient-derived nonhematopoietic stimulator cells in allograft engineering.
Nonn M; Herr W; Khan S; Todorova M; Link I; Thies J; Distler E; Kaltwasser M; Hoffmann J; Huber C; Hartwig UF
Transplantation; 2008 Nov; 86(10):1427-35. PubMed ID: 19034014
[TBL] [Abstract][Full Text] [Related]
34. The changing role of natural killer cells in solid organ rejection and tolerance.
Kitchens WH; Uehara S; Chase CM; Colvin RB; Russell PS; Madsen JC
Transplantation; 2006 Mar; 81(6):811-7. PubMed ID: 16570001
[TBL] [Abstract][Full Text] [Related]
35. Cellular immune reconstitution and its impact on clinical outcome in children with beta thalassemia major undergoing a matched related myeloablative allogeneic bone marrow transplant.
Rajasekar R; Mathews V; Lakshmi KM; George B; Viswabandya A; Chandy M; Srivastava A
Biol Blood Marrow Transplant; 2009 May; 15(5):597-609. PubMed ID: 19361752
[TBL] [Abstract][Full Text] [Related]
36. Human natural killer cells: news in the therapy of solid tumors and high-risk leukemias.
Pietra G; Vitale C; Pende D; Bertaina A; Moretta F; Falco M; Vacca P; Montaldo E; Cantoni C; Mingari MC; Moretta A; Locatelli F; Moretta L
Cancer Immunol Immunother; 2016 Apr; 65(4):465-76. PubMed ID: 26289090
[TBL] [Abstract][Full Text] [Related]
37. HLA-E/human beta2-microglobulin transgenic pigs: protection against xenogeneic human anti-pig natural killer cell cytotoxicity.
Weiss EH; Lilienfeld BG; Müller S; Müller E; Herbach N; Kessler B; Wanke R; Schwinzer R; Seebach JD; Wolf E; Brem G
Transplantation; 2009 Jan; 87(1):35-43. PubMed ID: 19136889
[TBL] [Abstract][Full Text] [Related]
38. Effect of cyclosporin A on interleukin-15-activated umbilical cord blood natural killer cell function.
Lin SJ; Kuo ML
Cytotherapy; 2008; 10(4):397-405. PubMed ID: 18574772
[TBL] [Abstract][Full Text] [Related]
39. Treatment of acute leukemia with unmanipulated HLA-mismatched/haploidentical blood and bone marrow transplantation.
Huang XJ; Liu DH; Liu KY; Xu LP; Chen H; Han W; Chen YH; Zhang XH; Lu DP
Biol Blood Marrow Transplant; 2009 Feb; 15(2):257-65. PubMed ID: 19167686
[TBL] [Abstract][Full Text] [Related]
40. The history and future prospective of haplo-identical stem cell transplantation.
Handgretinger R; Lang P
Cytotherapy; 2008; 10(5):443-51. PubMed ID: 18615344
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
